These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25100310)

  • 21. Methadone replacement therapy: tried, tested, effective?
    Robertson JR; Daniels AM
    J R Coll Physicians Edinb; 2012 Jun; 42(2):133-8. PubMed ID: 22693699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid agonist treatment for pharmaceutical opioid dependent people.
    Nielsen S; Larance B; Degenhardt L; Gowing L; Kehler C; Lintzeris N
    Cochrane Database Syst Rev; 2016 May; (5):CD011117. PubMed ID: 27157143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a 'microecologic technique' to study crime incidents around methadone maintenance treatment centers - a response: The journal publishes both invited and unsolicited letters.
    Gupta R; Sarkar S; Balhara YP
    Addiction; 2012 Oct; 107(10):1883. PubMed ID: 22831569
    [No Abstract]   [Full Text] [Related]  

  • 24. A pilot study assessing acceptability and feasibility of hatha yoga for chronic pain in people receiving opioid agonist therapy for opioid use disorder.
    Uebelacker LA; Van Noppen D; Tremont G; Bailey G; Abrantes A; Stein M
    J Subst Abuse Treat; 2019 Oct; 105():19-27. PubMed ID: 31443887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive function is largely intact in methadone maintenance treatment patients.
    Elkana O; Adelson M; Doniger GM; Sason A; Peles E
    World J Biol Psychiatry; 2019 Mar; 20(3):219-229. PubMed ID: 28610451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.
    Wu LT; John WS; Morse ED; Adkins S; Pippin J; Brooner RK; Schwartz RP
    Addiction; 2022 Feb; 117(2):444-456. PubMed ID: 34286886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use.
    Moore BA; Buono FD; Lloyd DP; Printz DMB; Fiellin DA; Barry DT
    J Subst Abuse Treat; 2019 Feb; 97():68-74. PubMed ID: 30577901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continued drug use during methadone treatment in China: a retrospective analysis of 19,026 service users.
    Sullivan SG; Wu Z; Cao X; Liu E; Detels R;
    J Subst Abuse Treat; 2014 Jul; 47(1):86-92. PubMed ID: 24629884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of lifetime psychiatric diagnosis on long-term retention and survival of former opiate addicts in methadone maintenance treatment.
    Peles E; Schreiber S; Domany Y; Adelson M
    World J Biol Psychiatry; 2014 Dec; 15(8):629-35. PubMed ID: 25140586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of coping and depression on abstinence from illicit drug use in methadone-maintained patients.
    Avants SK; Warburton LA; Margolin A
    Am J Drug Alcohol Abuse; 2000 Aug; 26(3):399-416. PubMed ID: 10976665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analgesic management of acute pain in patients receiving methadone or buprenorphine].
    Zinck L; Sonne NM; Madsen SL; Nikolajsen L
    Ugeskr Laeger; 2015 Mar; 177(10):. PubMed ID: 25749118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methadone treatment centers and crime: the journal publishes both invited and unsolicited letters.
    Mooney G
    Addiction; 2012 Nov; 107(11):2051-2; author reply 2052-3. PubMed ID: 23039754
    [No Abstract]   [Full Text] [Related]  

  • 33. Voucher-based reinforcement of opiate abstinence during methadone detoxification.
    Robles E; Stitzer ML; Strain EC; Bigelow GE; Silverman K
    Drug Alcohol Depend; 2002 Jan; 65(2):179-89. PubMed ID: 11772479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commentary on Boyd et al. (2012): debunking myths about methadone and crime.
    Nunn A; Rich J
    Addiction; 2012 Sep; 107(9):1639-40. PubMed ID: 22861676
    [No Abstract]   [Full Text] [Related]  

  • 35. Characteristics and quality of life of opioid-dependent pregnant women in Austria.
    Metz VE; Comer SD; Wuerzl J; Pribasnig A; Fischer G
    Arch Womens Ment Health; 2014 Dec; 17(6):529-39. PubMed ID: 25023716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
    Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
    Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China.
    Zhang B; Cai T; Yan Z; Mburu G; Wang B; Yang L
    Harm Reduct J; 2016 Feb; 13():8. PubMed ID: 26915361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study.
    Soyka M; Träder A; Klotsche J; Backmund M; Bühringer G; Rehm J; Wittchen HU
    J Clin Psychopharmacol; 2011 Oct; 31(5):678-80. PubMed ID: 21881461
    [No Abstract]   [Full Text] [Related]  

  • 39. A 12-month evaluation of health-related quality of life outcomes of methadone maintenance program in a rural Malaysian sample.
    Lua PL; Talib NS
    Subst Use Misuse; 2012 Aug; 47(10):1100-5. PubMed ID: 22545914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New formulation of methadone for opioid dependence in France: acceptability and diversion/misuse liability.
    Eiden C; Léglise Y; Bertomeu L; Clavel V; Faillie JL; Petit P; Peyrière H
    Therapie; 2013; 68(2):107-11. PubMed ID: 23773351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.